DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $108 | -5.3% | 451 | 0.0% | 0.01% | -11.1% |
| Q1 2023 | $114 | +26.7% | 451 | +32.6% | 0.01% | +12.5% |
| Q4 2022 | $90 | -99.9% | 340 | -40.5% | 0.01% | -42.9% |
| Q3 2022 | $147,000 | +34.9% | 571 | +32.5% | 0.01% | +55.6% |
| Q2 2022 | $109,000 | +22.5% | 431 | +42.7% | 0.01% | +28.6% |
| Q1 2022 | $89,000 | -10.1% | 302 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $99,000 | +3.1% | 302 | -4.4% | 0.01% | -12.5% |
| Q3 2021 | $96,000 | +77.8% | 316 | +58.0% | 0.01% | +100.0% |
| Q2 2021 | $54,000 | +20.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $45,000 | +2.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $44,000 | -69.7% | 200 | -70.4% | 0.00% | -75.0% |
| Q3 2020 | $145,000 | +21.8% | 675 | 0.0% | 0.02% | +14.3% |
| Q2 2020 | $119,000 | +325.0% | 675 | +237.5% | 0.01% | +250.0% |
| Q1 2020 | $28,000 | -60.6% | 200 | -56.8% | 0.00% | -50.0% |
| Q4 2019 | $71,000 | +144.8% | 463 | +131.5% | 0.01% | +100.0% |
| Q3 2019 | $29,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $29,000 | +11.5% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $26,000 | -62.9% | 200 | -70.4% | 0.00% | -63.6% |
| Q4 2018 | $70,000 | -28.6% | 675 | -25.5% | 0.01% | -15.4% |
| Q3 2018 | $98,000 | +7.7% | 906 | -1.9% | 0.01% | 0.0% |
| Q2 2018 | $91,000 | +24.7% | 924 | +24.7% | 0.01% | +30.0% |
| Q1 2018 | $73,000 | +180.8% | 741 | +165.6% | 0.01% | +233.3% |
| Q4 2017 | $26,000 | +8.3% | 279 | +1.5% | 0.00% | -25.0% |
| Q3 2017 | $24,000 | +4.3% | 275 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $23,000 | -4.2% | 275 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $24,000 | +14.3% | 275 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $21,000 | -25.0% | 275 | -23.8% | 0.00% | -20.0% |
| Q3 2016 | $28,000 | -36.4% | 361 | -17.2% | 0.01% | -37.5% |
| Q2 2016 | $44,000 | +33.3% | 436 | +24.6% | 0.01% | +14.3% |
| Q1 2016 | $33,000 | 0.0% | 350 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $33,000 | +10.0% | 350 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $30,000 | 0.0% | 350 | 0.0% | 0.01% | +20.0% |
| Q2 2015 | $30,000 | 0.0% | 350 | 0.0% | 0.01% | -16.7% |
| Q1 2015 | $30,000 | -88.3% | 350 | -88.3% | 0.01% | -88.2% |
| Q4 2014 | $257,000 | +851.9% | 3,000 | +757.1% | 0.05% | +750.0% |
| Q3 2014 | $27,000 | -3.6% | 350 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $28,000 | +7.7% | 350 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $26,000 | – | 350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
| Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
| Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
| CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
| MIROVA | 128,368 | $16,947,000 | 9.18% |
| Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
| Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
| Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
| Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |